Article
The Neosartorya (Aspergillus) fischeri antifungal protein NFAP2 has low potential to…
medRxiv · 2024 · Bende, G.; Zsindely, N.; Laczi, K.; Kristoffy, Z.; Papp, C.; Farkas, A.; Toth, L.; Saringer, S.; Bodai, L.; Rakhely, G.; Marx, F.; Galgoczy, L.
Key facts
| Title | The Neosartorya (Aspergillus) fischeri antifungal protein NFAP2 has low potential to trigger resistance development in Candida albicans in vitro |
|---|---|
| First author | Bende, G.; Zsindely, N.; Laczi, K.; Kristoffy, Z.; Papp, C.; Farkas, A.; Toth, L.; Saringer, S.; Bodai, L.; Rakhely, G.; Marx, F.; Galgoczy, L. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.05.14.594093 |
| Devices mentioned | K973350, K990827 |
| Product codes mentioned | JLX, KQP, JRR, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1